The medial region of the nucleus tractus solitarius (mNTS) is a key brain stem site controlling cardiovascular function, wherein ANG II modulates neuronal L-type Ca 2ϩ currents via activation of ANG II type 1 receptors (AT1R) and production of reactive oxygen species (ROS). ANG II type 2 receptors (AT2R) induce production of nitric oxide (NO), which may interact with ROS and modulate AT1R signaling. We sought to determine whether AT2R-mediated NO production occurs in mNTS neurons and, if so, to elucidate the NO source and the functional interaction with AT1R-induced ROS or Ca 2ϩ influx. Electron microscopic (EM) immunolabeling showed that AT2R and neuronal NO synthase (nNOS) are coexpressed in neuronal somata and dendrites receiving synapses in the mNTS. In the presence of the AT1R antagonist losartan, ANG II increased NO production in isolated mNTS neurons, an effect blocked by the AT2R antagonist PD123319, but not the angiotensin (1-7) antagonist D-Ala. Studies in mNTS neurons of nNOS-null or endothelial NOS (eNOS)-null mice established nNOS as the source of NO. ANG II-induced ROS production was enhanced by PD123319, the NOS inhibitor N G -nitro-Larginine (LNNA), or in nNOS-null mice. Moreover, in the presence of losartan, ANG II reduced voltage-gated L-type Ca 2ϩ current, an effect blocked by PD123319 or LNNA. We conclude that AT2R are closely associated and functionally coupled with nNOS in mNTS neurons. The resulting NO production antagonizes AT1R-mediated ROS and dampens L-type Ca 2ϩ currents. The ensuing signaling changes in the NTS may counteract the deleterious effects of AT1R on cardiovascular function.
superoxide; blood pressure; autonomic function; patch-clamp; voltage-gated Ca 2ϩ channels; electron microscopy THE NUCLEUS OF THE SOLITARY tract (NTS), the major site of termination of vagal afferents arising from aortic baroreceptors and cardiorespiratory chemoreceptors, plays a critical role in normal cardiovascular regulation and in the neurohumoral dysfunction associated with hypertension (7, 13, 21, 31) . The octapeptide ANG II is heavily expressed in the medial NTS (mNTS) and contributes to cardiovascular regulation and dysregulation, in large part, by activation of ANG II type 1 receptors (AT 1 R) and type 2 receptors (AT 2 R) (30, 33, 47) . One of the signaling mechanisms by which AT 1 R influence the mNTS neurons involves production of reactive oxygen species (ROS) by the enzyme NADPH oxidase (Nox) (18, 49, 50, 55) . AT 1 R-mediated ROS, in turn, enhance voltage-gated L-type Ca 2ϩ currents in the mNTS neurons, which may contribute to the deleterious cardiovascular effects of ANG II (45, 49, 50) . Much less is known, however, about the role of AT 2 R in the mNTS. AT 2 R are expressed in brain stem not only early in development, but also in adulthood (15, 17) . In other autonomic neurons, AT 2 R activation has been linked to production of nitric oxide (NO), which is thought to exert beneficial effects by counterbalancing some of the deleterious actions of AT 1 R activation (10, 15) . However, it is not known whether AT 2 R activation in the mNTS neurons triggers NO production. Furthermore, the spatial relationships between AT 2 R and NO synthase (NOS) have not been established. ROS react avidly with NO to generate a wide variety of nitrated species (19, 32) , and ROS levels can have a marked impact on NO availability and biological activity (22, 32) . Therefore, it is likely that ROS produced by AT 1 R activation modulate the bioavailability of NO produced by activation of AT 2 R, and vice versa. However, the functional interactions between AT 1 R-mediated ROS and AT 2 R-mediated NO in the mNTS neurons remain unclear, particularly in reference to L-type Ca 2ϩ currents, which have an important role in the function of the mNTS neurons (45, 49, 50) and are modulated by NO and ROS (5, 50) .
In this study, we sought to address some of these outstanding questions concerning the role of AT 2 R in the mNTS neurons. Using electron microscopic (EM) immunolabeling, we found that AT 2 R have a close spatial relationship with neuronal nitric oxide synthase (nNOS) in the mNTS neurons. Consistent with this finding, NO imaging studies in isolated mNTS neurons identified nNOS as the predominant source of NO. Finally, patch-clamping studies demonstrated that NO produced by AT 2 R activation dampens voltage-gated L-type Ca 2ϩ currents induced by ANG II. The findings suggest a powerful modulatory role of AT 2 R on Ca 2ϩ channel activity in the mNTS neurons, which is likely to have a major influence on the NTS function.
MATERIALS AND METHODS
All experiments were performed in compliance with the guidelines of the Institutional Animal Care and Use Committee at Weill Cornell Medical College.
Materials. Male Sprague-Dawley rats (2-3 wk old) were purchased from Charles River Laboratories. Mice were also used for EM study or to take advantage of knockout models to study the role of selected NOS isoforms and Nox2. C57BL/6J mice (wild-type controls), Nox2-null mice and nNOS-null mice (4 -6 wk old) were obtained from an in-house colony (20, 50) . Endothelial nitric oxide synthase (eNOS)-null mice were purchased from Jackson Laboratory. All null mice were on a C57BL6/J background. ANG II, PD123319, N G -nitro-Larginine (LNNA), and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO) were purchased from Sigma-Aldrich Chemical. D-Ala [A-779, (D-Ala7)-ANG I/II (1-7)] and ANG II-(1-7) were purchased from Bachem Bioscience Americas. Fluorescent dyes 4-amino-5-methylamino-2=,7=-difluorofluorescein diacetate (DAF-FM) and 6-carboxy-2=,7=-dichlorodihydro-fluorescein di(acetoxymethyl ester) (C-DCDHF-DA) were purchased from Invitrogen. Losartan was a gift from the DuPont Merck Pharmaceutical. The nNOS, glial fibrillary acidic protein (GFAP), and cluster of differentiation 3 (CD3) antibodies were purchased from BD Biosciences. The AT 2R Neun and Iba1 antibodies were purchased from Abcam.
Electron microscopy. EM dual-immunolabeling has been described previously (50) . Male wild-type mice were anesthetized with pentobarbital sodium, and their brains were fixed by perfusion with heparin-saline (1,000 U/ml) followed consecutively by 3.8% acrolein (Polysciences) in 2% paraformaldehyde in 0.1 mol/l phosphate buffer. Coronal sections of 40 m were cut through the mNTS starting at 7.32 caudal to bregma and ending at 7.76 caudal to bregma using a vibratome (Leica Microsystems), and all of the sections included were at the level of the area postrema (34) . The tissue sections were incubated for 48 h at 4°C in 0.1 mol/l Tris-buffered saline/0.1% BSA solution containing a 1:200 dilution of a mouse monoclonal nNOS antibody for immunoperoxidase labeling and a 1:1,000 dilution of a rabbit polyclonal AT 2R antiserum for immunogold-silver (9, 11) . The nNOS antibody (cat. no. 610309) was against a sequence at the C-terminal (amino acids 1095-1289) of human nNOS. Western blot analysis showed that the purified antiserum recognizes a single band of ϳ155 kDa, corresponding to the molecular weight of nNOS (44) . The AT 2R antiserum was against a synthetic peptide sequence from the COOH-terminal domain (amino acids 349 -363) of the rat AT2R (Abcam, cat. no. ab19134). This antiserum specifically recognizes AT2R in human cervical carcinoma (HeLa) cells transfected with AT2R, but not AT1R (11) . After the primary antisera incubation, the sections were placed for 30 min each in biotinylated secondary horse anti-mouse IgG (1:400; Incstar) and avidin-biotin peroxidase complex (ABC Elite Kit, Vector Laboratories). The bound peroxidase was visualized by reaction of the sections for 5 min in 3,3=-diaminobenzidine (Sigma-Aldrich) and hydrogen peroxide. For immunogold labeling, the sections were placed for 2 h in a 1:50 dilution of donkey anti-rabbit IgG conjugated with 1-nm colloidal gold, and a silver intense EM kit was used for 6 min to enhance bound gold particles (Amersham Biosciences). The sections were postfixed in 2% osmium tetroxide and embedded in EM bed-812. Single ultrathin sections (70 nm) containing the mNTS at the level of the area postrema were cut using an EM UC6 ultratome (Leica Microsystems) and collected and dried on 400-mesh copper grids. Ultrathin sections were then counter-stained for ultrastructural analysis using a Philips CM10 transmission electron microscope.
Dissociation of the mNTS neurons. As described in detail elsewhere (49, 50) , rats were killed by CO 2, the brain stem was quickly removed and transferred to a chamber containing ice-cold sucrose-artificial cerebrospinal fluid (aCSF) oxygenated with a mixed gas containing 95% O 2 and 5% CO2 (39, 40) . Although hypercapnia and hypoxia at death could influence NTS chemoreceptive neurons, these changes are likely to be reversed by equilibration of the tissue in 95% O2 and 5% CO2. Coronal slices (300 m in thickness) were obtained and incubated with 0.02% pronase and 0.02% thermolysin at 36°C in the oxygenated lactic acid (l)-aCSF. With the area postrema as a landmark, the mNTS region was punched, and its cells were mechanically dissociated. The mNTS neurons were identified based on their typical cellular morphology, e.g., small round or oval bipolar cells with long thin processes (49, 50) .
ROS or NO detection. Methods for ROS and NO detection have been described in detail elsewhere (20, 24 -26, 39, 49) and are briefly summarized. NO and ROS were detected using DAF-FM (20, 24 -26) Fig. 1. Electron micrographs illustrating angiotensin type 2 receptor (AT2R) and neuronal nitric oxide synthase (nNOS) coexpression in somatodendritic profiles in the mouse mNTS. A: immunogold labeling for the AT2R (red arrows) is seen in the cytoplasm near endomembranes (em) and the Golgi lamellae (Go) in a soma containing nNOS immunoreactivity (AT2R/nNOS-s). The peroxidase nNOS labeling (green arrows) is diffusely distributed throughout the cytoplasm, with a slightly denser distribution near endomembranes (em) and mitochondria (m). B: large vagal-like axon terminal containing one immunogold particle (red arrows, AT2R-t) on the plasma membrane is forming two synapses (yellow curved arrows) with a dually labeled dendrite (dd). The postsynaptic labeling for AT2R (red arrows) is seen in the cytoplasm, away from the synaptic inputs. C: unlabeled terminals form synapses (yellow curved arrow) with dual-labeled dendrites (dd-1 and dd-2). One of the dendrites (dd-2) shows a single AT2R gold particle (red arrows) located in the synaptic portion (yellow curved arrow) of the plasma membrane contacted by an unlabeled axon. An immunogold-labeled axon terminal (AT2-t) is seen in the neuropil. Scale bars ϭ 0.5 m.
and C-DCDHF-DA (39, 49) , respectively. The mNTS neurons were incubated with C-DCDHF-DA (5 mol/l) or DAF-FM (5 mol/l) in oxygenated l-aCSF for 30 min, and then rinsed in control buffer. Time-resolved fluorescence (FITC filter) was measured at 30-s intervals with a Nikon diaphot 300 inverted microscope equipped with CCD digital camera (Princeton Instruments) and using IPLab software (Scanalytics) (49) . Recordings were started after a stable baseline measurement was achieved, usually 10 min. For all experiments, concurrent vehicle recordings were performed. In some experiments, the cell type(s) producing NO was identified by immunofluorescence labeling with antibodies for the neuronal marker NeuN (1:500), the astrocytic marker GFAP (1:500), the microglial marker Iba1 (1:500), or the endothelial marker CD31 (1:500).
Whole-cell patch recording. Voltage-gated Ca 2ϩ currents were elicited from whole-cell patched NTS neurons. An Axopatch-200A patch-clamp amplifier was used with Cs ϩ electrode solution (49, 50) . Using 2 mM Ca 2ϩ as a charge carrier in oxygenated l-aCSF, we observed that inward Ca 2ϩ currents were elicited by a 500 msdepolarizing pulse from a holding potential of Ϫ60 mV to Ϫ10 mV using pClamp 8 (Axon Instruments). The amplitude of inward currents measured at the end of depolarizing pulses is considered as that of L-type Ca 2ϩ currents (49, 50) . Data analysis. The electron microscopy images were obtained exclusively at the surface (1-2 m) of the flat-embedded tissue, where penetration of the immunoreagents is optimal. Profiles containing two or more gold particles were considered to be immunogold-labeled. Peroxidase-immunoreactive profiles had a granular, electron-dense precipitate greater than that seen in any other morphologically similar profiles in the surrounding neuropil. Illustrations were prepared by importing digital images directly into Adobe Photoshop. ROS or NO fluorescence data are expressed as the ratio Ft/Fo, where Ft is fluorescence following the application of ANG II in a given cell, and Fo is the baseline fluorescence of the same cell immediately before application of ANG II. There was no relationship between baseline fluorescence (Fo) and the fluorescence increase induced by ANG II (Ft) under the experimental conditions studied (20, 49) . Data (mean Ϯ SE) were statistically evaluated by the paired Student's t-test, or ANOVA, as appropriate. P values Ͻ 0.05 were considered significant. with application of control buffer ANG II increases the NO signals (control: n ϭ 11; ANG II: 10 nmol/l, n ϭ 11; 30 nmol/l, n ϭ 11; 100 nmol/l, n ϭ 11; 4,000 nmol/l, n ϭ 11). Pretreatment of the AT1R antagonist losartan (Los, 3 mol/l) potentiated the NO signals induced by ANG II [10 nmol/l, 30 nmol/l, 100 nmol/l, and 4,000 nmol/l for control (n ϭ 6) and ANG II (n ϭ 6)]. C: application of losartan (3 M) and ANG II (100 nM) increases the NO signal in neurons (NeuN; n ϭ 26) but not in microglia (lba1; n ϭ 6), astrocytes (GFAP; n ϭ 4), or endothelial cells (CD31; n ϭ 5). *P Ͻ 0.05, **P Ͻ 0.01; paired Student's t-test or ANOVA was used.
RESULTS

AT 2 R are coexpressed with nNOS in somata and dendrites of the mNTS.
Immunogold labeling for AT 2 R was seen mainly within somatodendritic profiles, some of which also contained diffuse immunoperoxidase reaction product for nNOS in the mNTS of mouse (Fig. 1, A-C) or rat (data not shown) . In the soma, AT 2 R immunogold was detected away from the plasma membrane and near cytoplasmic organelles, including endomembrane of smooth endoplasmic reticulum and Golgi lamellae (Fig. 1A) . In dendrites, AT 2 R were localized to intracellular, as well as surface membranes. The surface labeling was evident on nonsynaptic, as well as synaptic portions of the plasmalemmal surface (Fig. 1, B and C) . Occasionally, AT 2 R gold particles were observed on the plasma membrane beneath a postsynaptic membrane specialization (Fig. 1C) . Dendrites containing AT 2 R and nNOS were among those that received synaptic contacts from axon terminals. Some of these terminals contained sparse AT 2 R immunolabeling (Fig. 1B) and were typical of glutamatergic visceral vagal afferents, forming multiple dendritic contacts (3). These results provide ultrastructural evidence that AT 2 R and nNOS are present in the same neurons.
Activation of AT 2 R increases NO production from nNOS. We used DAF-FM imaging to determine whether the AT 2 R activation results in NO production in the mNTS neurons. In the presence of control buffer (l-aCSF), ANG II (10 -4,000 nmol/l) had little effect on the NO signal (Fig. 2B) . However, in the presence of the AT 1 R antagonist losartan (3 mol/l), ANG II increased the NO signal markedly (Fig. 2B) . To determine the cellular source of NO, we examined NO-dependent fluorescence in neurons, microglia, astrocytes, and endothelial cells identified using cell-specific markers. We found that ANG II-induced NO fluorescence (P Ͻ 0.01 vs. control) was colocalized only with neurons (n ϭ 26) (Fig. 2C) . The enhancement of NO-dependent fluorescence by coapplication of ANG II with losartan was blocked by the AT 2 R antagonist PD123319 (30 mol/l, P Ͼ 0.05 vs. ANG II alone, n ϭ 9). NO-dependent fluorescence was also blocked by the cellpermeable NO scavenger PTIO (51) (50 mol/l, P Ͼ 0.05 vs. ANG II, n ϭ 14) or the NOS inhibitor LNNA (1 mmol/l, P Ͼ 0.05 vs. ANG II, N ϭ 6), attesting to the specificity of the NO signal. The ANG-(1-7) receptor antagonist D-Ala (2 mol/l) did not attenuate the increase in NO-dependent fluorescence induced by ANG II (P Ͼ 0.05 vs. losartan, n ϭ 8) (Fig. 3A) . Moreover, ANG-(1-7) (100 nM) did not increase NO-dependent fluorescence (P Ͼ 0.05 vs. losartan, n ϭ 9) (Fig. 3B) . We then used eNOS or nNOS-null mNTS neurons to examine the enzymatic source of NO. In the presence of losartan, ANG II (100 nmol/l) increased NO production in the mNTS neurons of wild type mice (P Ͻ 0.05 vs. control, n ϭ 6) or eNOS-null mice (P Ͻ 0.05 vs. control, n ϭ 9), but not in nNOS-null mice (P Ͼ 0.05 vs. control, n ϭ 9) (Fig. 4) . Therefore, nNOS is required for the NO production evoked by activation of AT 2 R.
AT 2 R-dependent NO production modulates AT 1 R-dependent ROS production. NO rapidly interacts with the ROS superoxide to produce peroxynitrite and other nitrated species (19, 32) . Therefore, we sought to determine whether the NO produced by activation of AT 2 R counteracts the ROS produced by activation of AT 1 R. In agreement with previous results (49, 50), ANG II, at a concentration producing maximal effects (1 mol/l), increased the ROS signal in rat mNTS neurons (P Ͻ 0.01 vs. control, n ϭ 16). The increase was blocked by the ROS scavenger Mn(III) tetrakis(4-benzoic acid)porphyrin chloride (30 mol/l, P Ͼ 0.01 vs. control, n ϭ 10), attesting to the specificity of the ROS signal. The ROS increase was also suppressed by losartan (3 mol/l, P Ͼ 0.05 vs. control, n ϭ 11), but it was facilitated by PD123319 (30 mol/l, P Ͻ 0.05 vs. ANG II alone, n ϭ 18), or LNNA (1 mmol/l, P Ͻ 0.05 vs. ANG II, n ϭ 7) (Fig. 5A ). ANG II (1 mol/l) also increased ROS production in wild-type mouse mNTS neurons (P Ͻ 0.01 vs. control, n ϭ 7). The ROS increase was blocked by losartan (3 mol/l, P Ͼ 0.05 vs. control, n ϭ 8) and was not observed in Nox2-null mice (P Ͻ 0.05 vs. control, n ϭ 9), confirming 
. AT2R-and NOS-dependent NO signals in rat mNTS neurons.
A: pretreatments with the AT2R antagonist PD123312 (PD; 30 mol/l, n ϭ 9), the NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO) (50 mol/l; n ϭ 14), or the NOS inhibitor N G -nitro-L-arginine (LNNA) (1 mmol/l, n ϭ 10) inhibited ANG II (100 nmol/l)-mediated potentiation of the NO signals (P Ͼ 0.05 vs. control). However, pretreatment with the angiotensin (1-7) receptor antagonist D-Ala (2 mol/l, n ϭ 8) did not affect the potentiation (P Ͻ 0.01 vs. control). B: ANG-(1-7) (100 nM), in the presence of losartan, does not affect the NO-dependent fluorescence of isolated mNTS neurons (n ϭ 9). *P Ͻ 0.05, **P Ͻ 0.01; paired Student's t-test or ANOVA.
Nox2 as the source of ROS. In contrast, the ROS production was enhanced in nNOS-null mNTS neurons (P Ͻ 0.05 vs. WT, n ϭ 9) (Fig. 5B) . These results indicate that the NO produced by AT 2 R activation suppresses the Nox2-derived ROS evoked by AT 1 R receptor activation.
AT 2 R-mediated NO production down-regulates L-type Ca 2ϩ
currents. ANG II increases voltage-gated L-type Ca 2ϩ currents in the mNTS neurons via AT 1 R activation and Nox2-derived ROS (49, 50) . Ca 2ϩ current enhancement in the mNTS plays a role in the mechanisms by which ANG II induces the neurohumoral dysfunction underlying hypertension (45) . To gain insight into the functional implications of the interplay between NO and ROS in the mNTS neurons, we examined the effect of the AT 2 R-mediated NO production on the Ca 2ϩ currents evoked by ANG II. Without losartan, ANG II (100 nmol/l) increased the amplitude of L-type Ca 2ϩ current (P Ͻ 0.01 vs. control, n ϭ 5) (Fig. 6, A and F) . However, in the presence of losartan, ANG II decreased the amplitude of L-type Ca 2ϩ current (P Ͻ 0.01 vs. control; n ϭ 7) (Fig. 6, B and F) , an effect blocked by PD123319 (30 mol/l) (Fig. 6, C and F) or LNNA (1 mmol/l) (Fig. 6, D and F) . We then used the NO donor SNAP to determine whether NO itself was able to downregulate ANG II-induced Ca 2ϩ currents. Consistent with this hypothesis, SNAP (2 mol/l) decreased the Ca 2ϩ current (P Ͻ 0.01 vs. control; n ϭ 6) (Fig. 6, E and F) . These findings indicate that NO produced by AT 2 R activation downregulates the ANG II-induced Ca 2ϩ current.
DISCUSSION
We have shown that AT 2 R are coexpressed with nNOS in somata and dendrites of mNTS neurons, and NO production by these neurons is markedly enhanced by AT 1 R inhibition. Such NO increase is prevented by an AT 2 R antagonist, suggesting the involvement of AT 2 R in the signaling pathway. Results in rats were generally comparable to those obtained in mice. Using NOS-null mice, we demonstrated that nNOS, not eNOS, is the source of NO. Interestingly, experiments with ANG-(1-7) and D-Ala suggested that, at variance with findings in other systems (54) , ANG-(1-7) or its receptor does not affect NO production in mNTS. Because of the close interaction between NO and ROS, we examined the effect of AT 2 R activation on ROS production. We found that AT 2 R inhibition or NOS inhibition enhances the ROS production evoked by ANG II. Similarly, ROS production was enhanced in nNOSnull mNTS neurons, an effect attenuated by AT 1 R inhibition. To determine the functional implications of the AT 2 R-dependent NO production, we tested its effect on voltage-gated L-type Ca 2ϩ currents, an important signaling mechanism in the mNTS neurons (45, 49, 50) . AT 1 R inhibition suppressed the Ca 2ϩ currents evoked by ANG II, an effect dependent on AT 2 R and NO. Taken together, these findings provide evidence of a reciprocal interaction between AT 2 R-dependent NO production and AT 1 R-dependent ROS production. The resulting balance between NO and ROS has an impact on voltage-gated Ca 2ϩ channels, which are critically involved in the functional output of the mNTS neurons (22) . Fig. 5 . AT2R-induced NO production antagonizes AT1R-induced reactive oxygen species (ROS) in the mNTS neurons. A: in rat mNTS neurons, ANG II (1 mol/l) increases the ROS signal (n ϭ 16), an effect blocked by the ROS scavenger Mn(III) tetrakis(4-benzoic acid)porphyrin chloride (30 mol/l; n ϭ 10) or the AT1R antagonist losartan (Los, 3 mol/l; n ϭ 11), but potentiated by the AT2R antagonist PD123319 (PD, 30 mol/l; n ϭ 18) or the NOS inhibitor LNNA (1 mmol/l; n ϭ 7). B: in mouse wild-type mNTS neurons, ANG II (1 mol/l) potentiated the ROS signal (n ϭ 7), an effect blocked by losartan (Los, 3 mol/l; n ϭ 8). However, ANG II (1 mol/l) reduced the ROS signal in Nox2-/-mNTS neurons (n ϭ 10). ANG II (1 mol/l) enhanced the ROS signal in nNOS-/-mNTS neurons (n ϭ 9), an effect completely blocked by pretreatment with losartan (Los; 3 mol/l; n ϭ 6). *P Ͻ 0.05; **P Ͻ 0.01; paired Student's t-test or ANOVA. Fig. 4 . AT2R-induced NO production is dependent on nNOS in mouse mNTS neurons. In the presence of losartan (3 mol/l), ANG II (100 nmol/l), potentiated NO production in wild-type (WT) (n ϭ 6) and eNOS-null mNTS neurons (n ϭ 9). However, the ANG II (100 nmol/l)-induced increase in NO was not observed in nNOS-null neurons (n ϭ 9). *P Ͻ 0.05; paired Student's t-test or ANOVA.
The present study sought to compare the findings from rats and mice, including genetically modified mice, to integrate all information derived from these two different models to generate a synergistic platform for understanding the roles of AT 2 R in nNOS-vs. eNOS-derived NO. Although it is not unlikely that the mechanisms underlying the AT 2 R-mediated NO release in the rat NTS is different from that in the mouse NTS, the similarities between rat and mice, from physiology to genomics, allows us to explain present findings obtained from the rat NTS neurons.
Somatodendritic profiles in the mNTS contain both AT 2 R and nNOS. The primary location of AT 2 R in the mNTS was in postsynaptic somata and dendrites, many of which also contained nNOS. The colocalization of AT 2 R and nNOS provides ultrastructural support for the functional interaction between ANG II and NO. In dual-labeled somatodendritic profiles, AT 2 R were present in the cytoplasmic compartment, associated with membranous structures involved in synthesis and intracellular trafficking of proteins to and from the surface (35, 43) . Plasmalemmal labeling of AT 2 R was occasionally seen in small-and medium-sized dendrites receiving synaptic input from one or more axon terminals. The presence of AT 2 R at the synapses in the nNOS-containing neuron suggests that activation of postsynaptic AT 2 R may result in generation of NO that presynaptically modulates the release of inhibitory and/or excitatory transmitters.
Age-dependent expression of AT 2 R. In contrast with early observations of mRNA of AT 2 R expression at very high levels in the fetus and its rapid regression to low levels in adults (37), recent publications using Western blot analysis shows that the brain stem from rat and mouse fetuses and neonates exhibit a significantly lower AT 2 R protein expression compared with adult rats (15, 17, 53) . These papers also show that 2-3-wk-old brain stem expresses considerable amounts of AT 2 R protein. Therefore, AT 2 R are also present in the adult brain stem, highlighting their physiological relevance (15, 17) .
AT 2 R induce nNOS-dependent NO production. NO is an important signaling molecule in the NTS, but its enzymatic source(s) and relationships to AT 2 R activation have not been clearly defined (17) . Some studies have provided evidence that NTS neurons are endowed with AT 2 R (27, 29, 36) . In addition, other reports show that NTS neurons express nNOS but not eNOS (14, 28) , whereas others have suggested that eNOS in the NTS plays a role in the regulation of blood pressure in spontaneously hypertensive rats (33, 48, 52) . The identification of the enzymatic sources of NO is complicated by the difficulties in selectively inhibiting specific NOS isoforms, especially eNOS (4) . To overcome this problem, in the present study, we used nNOS and eNOS-null mice and identified nNOS as the sole source of NO in the mNTS. However, on the basis of our observations in dissociated NTS cells in which AT 1 R were blocked, we cannot support or contradict the findings in vivo demonstrating the involvement of eNOSderived NO in the dampening of baroreceptor sensitivity induced by exogenous ANG II (33, 48, 52) . Our immunoelectron microscopy studies demonstrated a colocalization of nNOS and AT 2 R, providing ultrastructural evidence supporting a functional interaction between these proteins. However, the signaling pathways by which AT 2 R activate nNOS remain to be established. Activation of bradykinin receptors has been implicated in AT 2 R-induced NO production (42, 46), a finding not confirmed by other studies (1) . Therefore, the mechanisms linking AT 2 R activation to NO production remain to be elucidated.
Interaction between AT 1 R-derived ROS and AT 2 R-derived NO. NO reacts avidly with ROS to generate a nitrated species, some of which contribute to its physiological and pathological effects (8, 22, 23) . Our findings suggest that when neurons are exposed to ANG II, AT 2 R-induced NO is scavenged by AT 1 Rderived ROS. Thus, robust increases in NO are observed only if ROS production is suppressed by AT 1 R inhibition. Thus, robust increases in NO are observed only if ROS production is suppressed by AT 1 R inhibition. Conversely, the ROS production induced by AT 1 R activation is dampened by the NO produced by AT 2 R activation. In the normal state, ROS production predominates over NO production, and ROS can be detected, even in the absence of AT 2 R inhibition. However, as demonstrated here, AT 2 R inhibition reduces NO and potentiates AT 1 R-dependent ROS generation, suggesting that loss of NO enhances ROS availability. This effect is unlikely to be related to NO-induced Nox2 inhibition because NO does not suppress, but promotes, Nox2-dependent ROS formation (20) . Therefore, ROS and NO can reciprocally influence their bioavalability and biological activities in the mNTS neurons. Previous studies have demonstrated that AT 2 R facilitate vasodilation through NOS/NO-mediated signal after chronic AT 1 R antagonism and that AT 1 R antagonists increase both AT 2 R expression and cGMP (6, 40) . These effects may contribute, in part, to the beneficial actions of AT 1 R blockers in the treatment of hypertension. Thus, our finding that blockade of AT 1 R in NTS neurons may significantly enhance the AT 2 R-mediated NO release in vivo may have clinically relevant implications.
Effects on voltage-gated Ca 2ϩ channels. Voltage-gated Ltype Ca 2ϩ channels play an important role in neurotransmission and long-term potentiation, and, as such, are critical to neuronal function in the NTS. AT 2 R have been proposed to modulate neuronal Ca 2ϩ channel activity by NO through two different mechanisms, cGMP and S-nitrosylation (2). The present results suggest that AT 2 R activation suppresses Ca 2ϩ currents through NO production, whereas AT 1 R receptor activation enhances Ca 2ϩ currents via Nox2-derived ROS (49, 50) . The reduction in Ca 2ϩ currents by NO shown here is in agreement with similar findings in other neuronal types (5) . The mechanisms of the effects of NO on L-type Ca 2ϩ channels have not been elucidated in full, but they may include activation of soluble guanylyl cyclase or S-nitrosylation of Ca 2ϩ -handling proteins (2) .
Perspectives and Significance
We investigated the role of AT 2 R in the regulation of NO and ROS homeostasis in mNTS neurons. We found that AT 2 R and nNOS are colocalized at postsynaptic sites and that AT 2 R activation enhances NO production via activation of nNOS, while reducing the availability of ROS generated by AT 1 R activation via Nox2. These effects on NO and ROS have an impact on L-type Ca 2ϩ currents since AT 2 R-mediated NO attenuates the Ca 2ϩ currents triggered by AT 1 R activation. These results suggest that AT 2 R-mediated NO production may offset the deleterious effects of AT 1 R-mediated ROS in the mNTS, possibly, by suppressing L-type Ca 2ϩ currents. Our findings also unveil a previously unrecognized interaction between AT 1 R and AT 2 R in the NTS. Such interaction is relevant to clinical conditions, such as hypertension and cardiac failure, in which the balance between central AT 1 R and AT 2 R is altered (16) . Furthermore, AT 2 R-mediated NO may help explain the beneficial effects of AT 1 R inhibitors for the treatment of hypertension (12, 41) . Finally, the functional significance of the interaction between mNTS AT 1 R, and AT 2 R in the regulation of sympathetic outflow and blood pressure remains to be defined (12) . Further studies using in vitro and in vivo approaches will be required to address these outstanding questions.
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